Skip to main content
Top
Published in: Pediatric Nephrology 2/2009

Open Access 01-02-2009 | Educational Review

Acute kidney injury in children

Author: Sharon Phillips Andreoli

Published in: Pediatric Nephrology | Issue 2/2009

Login to get access

Abstract

Acute kidney injury (AKI) (previously called acute renal failure) is characterized by a reversible increase in the blood concentration of creatinine and nitrogenous waste products and by the inability of the kidney to regulate fluid and electrolyte homeostasis appropriately. The incidence of AKI in children appears to be increasing, and the etiology of AKI over the past decades has shifted from primary renal disease to multifactorial causes, particularly in hospitalized children. Genetic factors may predispose some children to AKI. Renal injury can be divided into pre-renal failure, intrinsic renal disease including vascular insults, and obstructive uropathies. The pathophysiology of hypoxia/ischemia-induced AKI is not well understood, but significant progress in elucidating the cellular, biochemical and molecular events has been made over the past several years. The history, physical examination, and laboratory studies, including urinalysis and radiographic studies, can establish the likely cause(s) of AKI. Many interventions such as ‘renal-dose dopamine’ and diuretic therapy have been shown not to alter the course of AKI. The prognosis of AKI is highly dependent on the underlying etiology of the AKI. Children who have suffered AKI from any cause are at risk for late development of kidney disease several years after the initial insult. Therapeutic interventions in AKI have been largely disappointing, likely due to the complex nature of the pathophysiology of AKI, the fact that the serum creatinine concentration is an insensitive measure of kidney function, and because of co-morbid factors in treated patients. Improved understanding of the pathophysiology of AKI, early biomarkers of AKI, and better classification of AKI are needed for the development of successful therapeutic strategies for the treatment of AKI.
Literature
1.
go back to reference Andreoli SP (2002) Acute renal failure. Curr Opin Pediatr 14:183–188PubMed Andreoli SP (2002) Acute renal failure. Curr Opin Pediatr 14:183–188PubMed
2.
go back to reference Moghal NE, Brocklebank JT, Meadow SR (1998) A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 49:91–95PubMed Moghal NE, Brocklebank JT, Meadow SR (1998) A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 49:91–95PubMed
3.
go back to reference Martin-Ancel A, Garcia-Alix A, Gaya F, Cabañas F, Burgueros M, Quero J (1995) Multiple organ involvement in perinatal asphyxia. J Pediatr 127:786–793PubMed Martin-Ancel A, Garcia-Alix A, Gaya F, Cabañas F, Burgueros M, Quero J (1995) Multiple organ involvement in perinatal asphyxia. J Pediatr 127:786–793PubMed
4.
go back to reference Karlowivz MG, Adelman RD (1995) Nonoliguric and oliguric acute renal failure. Pediatr Nephrol 9:718–722 Karlowivz MG, Adelman RD (1995) Nonoliguric and oliguric acute renal failure. Pediatr Nephrol 9:718–722
5.
go back to reference Andreoli SP (2004) Acute renal failure in the newborn. Semin Perinatol 28:112–123PubMed Andreoli SP (2004) Acute renal failure in the newborn. Semin Perinatol 28:112–123PubMed
6.
go back to reference Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L (2005) Potential risk factors for the development of acute renal failure in preterm newborn infants: a case controlled study. Arch Dis Child Fetal Neonatal Ed 90:514–519 Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L (2005) Potential risk factors for the development of acute renal failure in preterm newborn infants: a case controlled study. Arch Dis Child Fetal Neonatal Ed 90:514–519
7.
go back to reference Aggarwal A, Kumar P, Chowkhary G, Majumdar S, Narang A (2005) Evaluation of renal functions in asphyxiated newborns. J Trop Pediatr 51:295–299PubMed Aggarwal A, Kumar P, Chowkhary G, Majumdar S, Narang A (2005) Evaluation of renal functions in asphyxiated newborns. J Trop Pediatr 51:295–299PubMed
8.
go back to reference Airede A, Bello M, Werasingher HD (1997) Acute renal failure in the newborn: Incidence and outcome. J Paediatr Child Health 33:246–249PubMed Airede A, Bello M, Werasingher HD (1997) Acute renal failure in the newborn: Incidence and outcome. J Paediatr Child Health 33:246–249PubMed
9.
go back to reference Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101PubMed Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101PubMed
10.
go back to reference Fernandez C, Lopez-Herce J, Flores JC, Galaviz D, Rupérez M, Brandstrup KB, Bustinza A (2005) Prognosis in critically ill children requiring continuous renal replacement therapy. Pediatr Nephrol 20:1473–1477PubMed Fernandez C, Lopez-Herce J, Flores JC, Galaviz D, Rupérez M, Brandstrup KB, Bustinza A (2005) Prognosis in critically ill children requiring continuous renal replacement therapy. Pediatr Nephrol 20:1473–1477PubMed
11.
go back to reference Liano F, Pascual J, Madrid Acute Renal Failure Study Group (1996) Epidemiology of acute renal failure: a prospective, multicenter study community-based study. Kidney Int 50:811–818PubMed Liano F, Pascual J, Madrid Acute Renal Failure Study Group (1996) Epidemiology of acute renal failure: a prospective, multicenter study community-based study. Kidney Int 50:811–818PubMed
12.
go back to reference Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–934PubMed Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–934PubMed
13.
go back to reference Vasarhelyi B, Toth-Heyn P, Treszl A, Tulassay T (2005) Genetic polymorphism and risk for acute renal failure in preterm infants. Pediatr Nephrol 20:132–135PubMed Vasarhelyi B, Toth-Heyn P, Treszl A, Tulassay T (2005) Genetic polymorphism and risk for acute renal failure in preterm infants. Pediatr Nephrol 20:132–135PubMed
14.
go back to reference Nobilis A, Kocsis I, Toth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor genotype does not influence the risk of neonatal acute renal failure. Pediatr Nephrol 16:1063–1066PubMed Nobilis A, Kocsis I, Toth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor genotype does not influence the risk of neonatal acute renal failure. Pediatr Nephrol 16:1063–1066PubMed
15.
go back to reference Treszl A, Toth-Heyn P, Koscic I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717PubMed Treszl A, Toth-Heyn P, Koscic I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717PubMed
16.
go back to reference Fekete A, Treszl A, Toth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in neonates. Pediatr Res 54:452–455PubMed Fekete A, Treszl A, Toth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in neonates. Pediatr Res 54:452–455PubMed
17.
go back to reference Kelly KJ, Baird NR, Greene AL (2001) Induction of stress response proteins and experimental renal ischemia/reperfusion. Kidney Int 59:1798–1802PubMed Kelly KJ, Baird NR, Greene AL (2001) Induction of stress response proteins and experimental renal ischemia/reperfusion. Kidney Int 59:1798–1802PubMed
18.
go back to reference Devarajan P (2007) Emerging biomarkers of AKI. Contrib Nephrol 156:203–312PubMed Devarajan P (2007) Emerging biomarkers of AKI. Contrib Nephrol 156:203–312PubMed
19.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure—definition, outcomes measures, animal models, fluid therapy and information technology needs. Crit Care 8:R204–R212PubMedPubMedCentral Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure—definition, outcomes measures, animal models, fluid therapy and information technology needs. Crit Care 8:R204–R212PubMedPubMedCentral
20.
go back to reference Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMed Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMed
21.
go back to reference Bagga A, Bakkaloglu A, Devarajan P, Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Joannidis M, Levin A, Acute Kidney Injury Network (2007) Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol 22:1655–1658PubMed Bagga A, Bakkaloglu A, Devarajan P, Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Joannidis M, Levin A, Acute Kidney Injury Network (2007) Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol 22:1655–1658PubMed
22.
go back to reference Lip GYH, Churchill D, Beevers M, Auckett A, Beevers DG (1997) Angiotensin converting enzyme inhibitors in early pregnancy. Lancet 350:1446–1447PubMed Lip GYH, Churchill D, Beevers M, Auckett A, Beevers DG (1997) Angiotensin converting enzyme inhibitors in early pregnancy. Lancet 350:1446–1447PubMed
23.
go back to reference Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Bugler MC (2001) Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358:241–242PubMed Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Bugler MC (2001) Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358:241–242PubMed
24.
go back to reference Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451PubMed Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451PubMed
25.
go back to reference Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal acute renal failure. Pediatr Nephrol 19:232–234PubMed Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal acute renal failure. Pediatr Nephrol 19:232–234PubMed
26.
go back to reference van Bel F, Guit GL, Schipper J, van de Bor M, Baan J (1991) Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 118:621–626PubMed van Bel F, Guit GL, Schipper J, van de Bor M, Baan J (1991) Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 118:621–626PubMed
27.
go back to reference Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810PubMed Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810PubMed
28.
go back to reference Gouyon JB, Guignard JP (2000) Management of acute renal failure in newborns. Pediatr Nephrol 14:1037–1040PubMed Gouyon JB, Guignard JP (2000) Management of acute renal failure in newborns. Pediatr Nephrol 14:1037–1040PubMed
29.
go back to reference Mathew OP, Jones AS, James E, Bland H, Groshong T (1980) Neonatal renal failure: usefulness of diagnostic indices. Pediatrics 65:57–60PubMed Mathew OP, Jones AS, James E, Bland H, Groshong T (1980) Neonatal renal failure: usefulness of diagnostic indices. Pediatrics 65:57–60PubMed
30.
go back to reference Ellis EN, Arnold WC (1982) Use of urinary indexes in renal failure in the newborn. Am J Dis Child 136:615–617PubMed Ellis EN, Arnold WC (1982) Use of urinary indexes in renal failure in the newborn. Am J Dis Child 136:615–617PubMed
31.
go back to reference Basile DP (2007) The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 72:151–156PubMed Basile DP (2007) The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 72:151–156PubMed
32.
go back to reference Sutton TA, Fisher CJ, Molitoris BA (2002) Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62:1539–1549PubMed Sutton TA, Fisher CJ, Molitoris BA (2002) Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62:1539–1549PubMed
33.
go back to reference Molitoris BA (1997) Putting the actin cytoskeleton into perspective: Pathophysiology of ischemic alterations. Am J Physiol 272:F430–F433PubMed Molitoris BA (1997) Putting the actin cytoskeleton into perspective: Pathophysiology of ischemic alterations. Am J Physiol 272:F430–F433PubMed
34.
go back to reference Andreoli SP (1991) Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 5:733–742PubMed Andreoli SP (1991) Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 5:733–742PubMed
35.
go back to reference Andreoli SP, McAteer JA (1990) Reactive oxygen molecule mediated injury in endothelial cells and renal tubular epithelial cells in vitro. Kidney Int 38:785–794PubMed Andreoli SP, McAteer JA (1990) Reactive oxygen molecule mediated injury in endothelial cells and renal tubular epithelial cells in vitro. Kidney Int 38:785–794PubMed
36.
go back to reference Kelly KJ, Williams WW, Colvin RB, Bonventre JV (1994) Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 91:812–817PubMedPubMedCentral Kelly KJ, Williams WW, Colvin RB, Bonventre JV (1994) Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 91:812–817PubMedPubMedCentral
37.
go back to reference Goligorsky MS, Brodsky SV, Noiri E (2002) Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61:855–861PubMed Goligorsky MS, Brodsky SV, Noiri E (2002) Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61:855–861PubMed
38.
go back to reference Gorligosky MS, Noiri E (1999) Duality of nitric oxide in acute renal failure. Semin Nephrol 19:263–271 Gorligosky MS, Noiri E (1999) Duality of nitric oxide in acute renal failure. Semin Nephrol 19:263–271
39.
go back to reference Radi R, Peluffo G, Alvarex MN, Vaviliat M, Cayota A (2001) Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30:463–488PubMed Radi R, Peluffo G, Alvarex MN, Vaviliat M, Cayota A (2001) Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30:463–488PubMed
40.
go back to reference Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA (1999) Endothelin up regulation and localization following renal ischemia and reperfusion. Kidney Int 55:1011–1018PubMed Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA (1999) Endothelin up regulation and localization following renal ischemia and reperfusion. Kidney Int 55:1011–1018PubMed
41.
go back to reference Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Luscher TF (1999) Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol 10:953–962PubMed Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Luscher TF (1999) Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol 10:953–962PubMed
42.
go back to reference Forbes JH, Hewitson TD, Becker GJ, Jones CL (2001) Simultaneous blockage of endothelin A and B receptors in ischemic acute renal failure is detrimental to long term kidney function. Kidney Int 59:1333–1341PubMed Forbes JH, Hewitson TD, Becker GJ, Jones CL (2001) Simultaneous blockage of endothelin A and B receptors in ischemic acute renal failure is detrimental to long term kidney function. Kidney Int 59:1333–1341PubMed
43.
go back to reference Zuk A, Bonventre JV, Brown D, Matlin KS (1998) Polarity, integrin and extracellular matrix dynamics in the post ischemic rat kidney. Am J Physiol 275:C711–C731PubMed Zuk A, Bonventre JV, Brown D, Matlin KS (1998) Polarity, integrin and extracellular matrix dynamics in the post ischemic rat kidney. Am J Physiol 275:C711–C731PubMed
44.
go back to reference Kwon O, Corrigan G, Meyers BD, Sibley R, Scandling JD, Dafoe D, Alfrey E, Nelson WJ (1999) Sodium reabsorption and distribution of Na+K+ATPase during post-ischemic injury to the renal allograft. Kidney Int 55:963–975PubMed Kwon O, Corrigan G, Meyers BD, Sibley R, Scandling JD, Dafoe D, Alfrey E, Nelson WJ (1999) Sodium reabsorption and distribution of Na+K+ATPase during post-ischemic injury to the renal allograft. Kidney Int 55:963–975PubMed
45.
go back to reference Van Why SK, Mann AS, Ardito T, Thulin G, Ferris S, Macleod MA, Kashgarin M, Siegel NJ (2002) Hsp27 associates with actin and limits injury in energy depleted renal epithelial. J Am Soc Nephrol 13:2667–2680 Van Why SK, Mann AS, Ardito T, Thulin G, Ferris S, Macleod MA, Kashgarin M, Siegel NJ (2002) Hsp27 associates with actin and limits injury in energy depleted renal epithelial. J Am Soc Nephrol 13:2667–2680
46.
go back to reference Luster AD (1998) Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445PubMed Luster AD (1998) Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445PubMed
47.
go back to reference Heinzelmann M, Mercer–Jones MA, Passmore JC (1999) Neutrophils and renal failure. Am J Kidney Dis 34:384–399PubMed Heinzelmann M, Mercer–Jones MA, Passmore JC (1999) Neutrophils and renal failure. Am J Kidney Dis 34:384–399PubMed
48.
go back to reference Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA, The PICARD Group (2004) Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449–2456PubMed Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA, The PICARD Group (2004) Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15:2449–2456PubMed
49.
go back to reference Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term outcome. Am J Physiol 281:F887–F899 Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term outcome. Am J Physiol 281:F887–F899
50.
go back to reference Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314–326PubMed Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314–326PubMed
51.
go back to reference Andreoli SP, Clark JH, McGuire WA, Bergstein JM (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 109:292–298PubMed Andreoli SP, Clark JH, McGuire WA, Bergstein JM (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 109:292–298PubMed
52.
go back to reference Stapleton FB, Strother DR, Roy S, Wyatt RJ, McKay CP, Murphy SB (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics 82:863–869PubMed Stapleton FB, Strother DR, Roy S, Wyatt RJ, McKay CP, Murphy SB (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics 82:863–869PubMed
53.
go back to reference Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9:206–212PubMed Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9:206–212PubMed
54.
go back to reference LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu SY, Mortiz M (2007) Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatr Nephrol 22:132–135PubMed LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu SY, Mortiz M (2007) Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatr Nephrol 22:132–135PubMed
55.
go back to reference Rampello E, Tiziana F, Malaguarnera M (2006) The management of tumor lysis syndrome. Nat Clin Pract Oncol 3:438–447PubMed Rampello E, Tiziana F, Malaguarnera M (2006) The management of tumor lysis syndrome. Nat Clin Pract Oncol 3:438–447PubMed
56.
go back to reference Boles JM, Detel JL, Briere J, Mialon P, Robasckiewicz M, Garre M, Briere J (1984) Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of acute lymphoblastic leukemia. Cancer 53:2425–2494PubMed Boles JM, Detel JL, Briere J, Mialon P, Robasckiewicz M, Garre M, Briere J (1984) Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of acute lymphoblastic leukemia. Cancer 53:2425–2494PubMed
57.
go back to reference Vohra S, Eddy A, Levin AV, Taylor G, Laxer RM (1999) Tubulointerstitial nephritis and uveitis in children and adolescents. Pediatr Nephrol 13:426–432PubMed Vohra S, Eddy A, Levin AV, Taylor G, Laxer RM (1999) Tubulointerstitial nephritis and uveitis in children and adolescents. Pediatr Nephrol 13:426–432PubMed
58.
go back to reference Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of shiga toxin associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760PubMedPubMedCentral Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of shiga toxin associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760PubMedPubMedCentral
59.
go back to reference Anochie I, Eke F (2005) Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 20:1610–1614PubMed Anochie I, Eke F (2005) Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 20:1610–1614PubMed
60.
go back to reference Olowu WA, Adelusola KA (2004) Pediatric acute renal failure in southwestern Nigeria. Kidney Int 66:1541–1548PubMed Olowu WA, Adelusola KA (2004) Pediatric acute renal failure in southwestern Nigeria. Kidney Int 66:1541–1548PubMed
61.
go back to reference Jenik AG, Ceriani Cernadas JM, Gorenstein A, Ramirez JA, Vain N, Armadans M, Ferraris JR (2000) A randomized, double blind, placebo controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 105:849–853 Jenik AG, Ceriani Cernadas JM, Gorenstein A, Ramirez JA, Vain N, Armadans M, Ferraris JR (2000) A randomized, double blind, placebo controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 105:849–853
62.
go back to reference Bakr AF (2005) Prophylactic theophylline to prevent renal dysfunction in term newborns exposed to perinatal asphyxia—a study in a developing country. Pediatr Nephrol 20:1249–1253PubMed Bakr AF (2005) Prophylactic theophylline to prevent renal dysfunction in term newborns exposed to perinatal asphyxia—a study in a developing country. Pediatr Nephrol 20:1249–1253PubMed
63.
go back to reference Bhat M, Shah Z, Makidoomi MS, Mufti MH (2006) Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo controlled trial. J Pediatr 149:180–183PubMed Bhat M, Shah Z, Makidoomi MS, Mufti MH (2006) Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo controlled trial. J Pediatr 149:180–183PubMed
64.
go back to reference Cantarovich F, Rangoonwala, B, Loremz H, Verho M, Esnault VL, High-Dose Furosemide in Acute Renal Failure Study Group (2004) High dose furosemide for established ARF: a prospective, randomized, double blind, placebo controlled, multicenter trial. Am J Kidney Dis 44:402–409 Cantarovich F, Rangoonwala, B, Loremz H, Verho M, Esnault VL, High-Dose Furosemide in Acute Renal Failure Study Group (2004) High dose furosemide for established ARF: a prospective, randomized, double blind, placebo controlled, multicenter trial. Am J Kidney Dis 44:402–409
65.
go back to reference Kellum JA (1998) Use of diuretics in the acute care setting. Kidney Int 1998 53:67–70 Kellum JA (1998) Use of diuretics in the acute care setting. Kidney Int 1998 53:67–70
66.
go back to reference Mehta R, Pascaul MT, Soroko S, Chertow GM (2002) Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547–2553PubMed Mehta R, Pascaul MT, Soroko S, Chertow GM (2002) Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547–2553PubMed
67.
go back to reference Bellomo R, Chapman M, Finfer S, Hicklling K, Myburgh J (2000) Low dose dopamine in patients with early renal dysfunction: a placebo controlled randomised trial. Lancet 356:2139–2143PubMed Bellomo R, Chapman M, Finfer S, Hicklling K, Myburgh J (2000) Low dose dopamine in patients with early renal dysfunction: a placebo controlled randomised trial. Lancet 356:2139–2143PubMed
68.
go back to reference Kellum JA, Decker JM (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526PubMed Kellum JA, Decker JM (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526PubMed
69.
go back to reference Lauschke A, Teichgraber UKM, Frei U, Eckardt KU (2006) “Low-dose” dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69:1669–1674PubMed Lauschke A, Teichgraber UKM, Frei U, Eckardt KU (2006) “Low-dose” dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69:1669–1674PubMed
70.
go back to reference Marik PE (2002) Low-dose dopamine: a systemic review. Intensive Care Med 28:877–883PubMed Marik PE (2002) Low-dose dopamine: a systemic review. Intensive Care Med 28:877–883PubMed
71.
go back to reference Friedrich JO, Adhikari N, Herridge MS, Beyene J (2005) Meta-analysis: low dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Int Med 142:510–524PubMed Friedrich JO, Adhikari N, Herridge MS, Beyene J (2005) Meta-analysis: low dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Int Med 142:510–524PubMed
72.
go back to reference Marthur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR (1999) The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27:1832–1837 Marthur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR (1999) The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27:1832–1837
73.
go back to reference Landoni G, Biondi-Zoccai GGL, Tumlin JA (2007) Beneficial Impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49:56–68PubMed Landoni G, Biondi-Zoccai GGL, Tumlin JA (2007) Beneficial Impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 49:56–68PubMed
74.
go back to reference Knoderer CA, Leiser JD, Nailescu C, Turrentine MW, Andreoli SP (2008) Fenoldopam for acute kidney injury in children. Pediatr Nephrol 23:495–498PubMed Knoderer CA, Leiser JD, Nailescu C, Turrentine MW, Andreoli SP (2008) Fenoldopam for acute kidney injury in children. Pediatr Nephrol 23:495–498PubMed
75.
go back to reference Kohda Y, Chiao H, Starr RA (1998) A melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats. Curr Opin Nephrol Hypertens 99:1165–1172 Kohda Y, Chiao H, Starr RA (1998) A melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats. Curr Opin Nephrol Hypertens 99:1165–1172
76.
go back to reference Weston CE, Feibelman MB, Wu K, Simon EE (1999) Effect of oxidant stress on growth factor stimulation of proliferation in cultured human proximal tubular cells. Kidney Int 56:1274–1276PubMed Weston CE, Feibelman MB, Wu K, Simon EE (1999) Effect of oxidant stress on growth factor stimulation of proliferation in cultured human proximal tubular cells. Kidney Int 56:1274–1276PubMed
77.
go back to reference Chatterjee PK, Cuzzocreas S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C (2000) Tempol, a membrane permeable radical scavenger reduces oxidant stress mediated renal dysfunction and injury in the rat. Kidney Int 58:658–673PubMed Chatterjee PK, Cuzzocreas S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C (2000) Tempol, a membrane permeable radical scavenger reduces oxidant stress mediated renal dysfunction and injury in the rat. Kidney Int 58:658–673PubMed
78.
go back to reference Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C (2005) Administered mesenchymal stem cells enhance recovery from ischemic/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613–1617PubMed Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C (2005) Administered mesenchymal stem cells enhance recovery from ischemic/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613–1617PubMed
79.
go back to reference Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH (1997) Anaritide in acute tubular necrosis. N Engl J Med 336:828–834PubMed Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH (1997) Anaritide in acute tubular necrosis. N Engl J Med 336:828–834PubMed
80.
go back to reference Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O’Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler HP (1999) Multicenter clinical trial of recombinant human insulin-like growth factor in patients with acute renal failure. Kidney Int 55:2423–2432PubMed Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O’Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler HP (1999) Multicenter clinical trial of recombinant human insulin-like growth factor in patients with acute renal failure. Kidney Int 55:2423–2432PubMed
81.
go back to reference Molitoris BA (2003) Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14:165–267 Molitoris BA (2003) Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14:165–267
82.
go back to reference Jo SK, Rosner MH, Okusa MD (2007) Pharmacologic treatment of acute kidney injury: why drugs haven’t worked and what is on the horizon. Clin J Am Soc Nephrol 2:356–365PubMed Jo SK, Rosner MH, Okusa MD (2007) Pharmacologic treatment of acute kidney injury: why drugs haven’t worked and what is on the horizon. Clin J Am Soc Nephrol 2:356–365PubMed
83.
go back to reference Metha RL, Pascual MT, Soroko S, Chertow GM (2002) Diuretics, mortality and non-recovery of renal function in acute renal failure. JAMA 228:2547–2553 Metha RL, Pascual MT, Soroko S, Chertow GM (2002) Diuretics, mortality and non-recovery of renal function in acute renal failure. JAMA 228:2547–2553
84.
go back to reference Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051–2058PubMed Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051–2058PubMed
85.
go back to reference Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein S (2006) 1–5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184–189PubMed Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein S (2006) 1–5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184–189PubMed
86.
go back to reference Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montane B, Zilleruelo G (2005) Comparative renal histomorphometry: a case study of oliogonephropathy of prematurity. Pediatr Nephrol 20:945–949PubMed Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montane B, Zilleruelo G (2005) Comparative renal histomorphometry: a case study of oliogonephropathy of prematurity. Pediatr Nephrol 20:945–949PubMed
87.
go back to reference Abitbol CL, Bauer CR, Montane B, Chandar J, Duara S, Zilleruelo G (2003) Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 18:887–893PubMed Abitbol CL, Bauer CR, Montane B, Chandar J, Duara S, Zilleruelo G (2003) Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 18:887–893PubMed
88.
go back to reference Polito C, Papale MR, LaManna AL (1998) Long term prognosis of acute renal failure in the full term newborn. Clin Pediatr (Phila) 37:381–386 Polito C, Papale MR, LaManna AL (1998) Long term prognosis of acute renal failure in the full term newborn. Clin Pediatr (Phila) 37:381–386
89.
go back to reference Kist-van Holthe JE, Van Zwet JM, Brand R, Van Weel MH, Vossen JM, van der Heijden AJ (2002) Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 17:1032–1037PubMed Kist-van Holthe JE, Van Zwet JM, Brand R, Van Weel MH, Vossen JM, van der Heijden AJ (2002) Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 17:1032–1037PubMed
Metadata
Title
Acute kidney injury in children
Author
Sharon Phillips Andreoli
Publication date
01-02-2009
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 2/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1074-9

Other articles of this Issue 2/2009

Pediatric Nephrology 2/2009 Go to the issue